Answers are grounded in this paper and cite their sources.
This study demonstrates that the level of proteinuria at 12 months is the individual best predictor of long-term renal outcome in patients with lupus nephritis. Inclusion of urinary RBCs as part of a composite outcome measure actually undermined the predictive value of the trial data. We therefore suggest that urinary RBCs should not be included as a component of clinical trial response criteria in lupus nephritis.
No takes yet. Share an insight, caveat, or question.
Dall’Era et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: